Halt on Johnson & Johnson vaccine remains for now

Johnson & Johnson’s COVID-19 vaccine will remain in limbo a while longer after U.S. health advisors told the government Wednesday that they need more evidence to decide whether a handful of unusual blood clots were linked to the shot — and if so, how big the potential risk is.

The reports are exceedingly rare — six cases out of more than 7 million U.S. inoculations with the one-dose vaccine. But the government recommended a pause in J&J vaccinations this week, not long after European…

Click here to view the original article.

Show More

Related Articles

Back to top button